For example, SMA patients present with a higher susceptibility to infection (Deguise and Kothary, 2017) and given the immunosuppression which follows prolonged mTOR inhibition, it may be more advantageous to consider compounds capable of activating autophagy independent of mTOR inhibition. This evidence concerns the gene MTOR and proximal spinal muscular atrophy.